Pfizer documents: Pharmacokinetics Written Summary

Released March 1, 2022

The ADME profile of BNT162b2 (BioNTech code number BNT162, Pfizer code number PF-07302048) included evaluation of the PK and metabolism of two novel lipid excipients (ALC-0315 and ALC-0159) in the LNP and potential biodistribution using luciferase expression as a surrogate reporter or a radiolabeled lipid marker … Over 48 hours, the radiolabel distributed mainly to the liver, adrenal glands, spleen and ovaries, with maximum concentrations observed at 8-48 hours post-dose.

You might also be interested in

Latest articles

Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, Peter A. McCullough Innate immune...
Geert Vanden Bossche When a deep understanding of immunology, virology, vaccinology, evolutionary...
Stefan Lanka The present notion of a virus is based on the...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Stay up to date

Sign up to our newsletter to get the latest health-related news and events delivered straight to your inbox.

Become a CHA member

Become an active value-added member and trusted provider of medical and healthcare information and education by joining the CHA Membership Program.

Your donation helps us stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.